https://www.selleckchem.com/pr....oducts/bodipy-493-50
During the study period, there were 371 nonfatal overdose events, with 179 (40.1%) participants reporting ≥1. In adjusted analysis, the consistently low (AOR=1.73, 95% CI=1.10, 2.71) and decreasing (AOR=1.87, 95% CI=1.18, 2.95) retention trajectories were positively associated with increased odds of nonfatal overdose compared with the consistently high opioid agonist therapy retention class. Suboptimal trajectories of opioid agonist therapy retention were associated with an increased likelihood of nonfatal overdose. These finding